Hsbc Holdings PLC Cardiovascular Systems Inc Transaction History

Hsbc Holdings PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$12.74 - $15.12 $27,212 - $32,296	2,136 Added 18.12%	13,926 $189,000
Q3 2022 Nov 14, 2022	BUY	$12.93 - $17.17 $13,085 - $17,376	1,012 Added 9.39%	11,790 $169,000
Q2 2022 Aug 11, 2022	SELL	$13.53 - $23.34 $14,287 - $24,647	-1,056 Reduced 8.92%	10,778 $156,000
Q1 2022 May 16, 2022	BUY	$16.14 - $22.6 $191,000 - $267,448	11,834 New	11,834 $270,000
Q3 2021 Nov 12, 2021	SELL	$32.83 - $43.0 $203,152 - $266,084	-6,188 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$34.41 - $44.03 $29,695 - $37,997	863 Added 16.21%	6,188 $263,000
Q1 2021 May 14, 2021	SELL	$37.29 - $47.19 $85,021 - $107,593	-2,280 Reduced 29.98%	5,325 $204,000
Q4 2020 Feb 12, 2021	BUY	$34.3 - $44.09 $49,426 - $63,533	1,441 Added 23.38%	7,605 $332,000
Q3 2020 Nov 12, 2020	BUY	$27.86 - $39.35 $171,729 - $242,553	6,164 New	6,164 $237,000
Q2 2019 Aug 13, 2019	SELL	$33.93 - $43.66 $723,760 - $931,311	-21,331 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$26.74 - $41.32 $653,097 - $1.01 Million	-24,424 Reduced 53.38%	21,331 $825,000
Q4 2018 Feb 13, 2019	BUY	$25.26 - $38.43 $1.16 Million - $1.76 Million	45,755 New	45,755 $1.3 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.